Perinatal Mental Health and Suicide Risk Prevention

Screening for Perinatal Depression and Identification of Suicide Risk

Psychiatric morbidity and mortality among pregnant or postpartum adolescent patients constitute a public health emergency, with maternal suicide ranking as one of the leading causes of indirect maternal mortality in this population group.

The combination of neurobiological immaturity, the emotional lability characteristic of adolescence, and the adaptive stress of motherhood increases vulnerability to severe depression, anxiety disorders, and postpartum psychotic episodes.

To mitigate these adverse outcomes, prenatal care and postpartum follow-up should incorporate structured, universal screening using validated psychometric instruments, primarily the Edinburgh Postnatal Depression Scale (EPDS) and the Patient Health Questionnaire (PHQ-9).

These diagnostic tools allow for distinguishing between transient postpartum dysphoria (maternity blues) and the onset of major perinatal depression.

During the clinical examination, healthcare providers should systematically and empathetically inquire about a history of non-suicidal self-injury, previous episodes of mood disturbance, a history of interpersonal violence, and the presence of thoughts of death or structured suicide plans.

The timely identification of behavioral warning signs—such as persistent anhedonia, overwhelming feelings of guilt, extreme social isolation, or direct expressions of an inability to care for the newborn—is vital for initiating priority referral pathways to psychiatric and clinical psychology services before an irreversible crisis occurs.

Psychopharmacology and Crisis Management in Pregnant Adolescents

The therapeutic approach to perinatal affective disorders in adolescents requires an individualized plan that rigorously weighs the risk-benefit ratio, recognizing that the adverse effects of untreated severe depression far outweigh the potential risks of timely medical intervention.

In mild to moderate cases, evidence-based psychotherapies—particularly cognitive-behavioral therapy and interpersonal psychotherapy adapted for adolescents—constitute the first line of treatment.

However, in cases of severe depressive episodes, complex psychiatric comorbidity, or imminent suicide risk, psychopharmacological treatment is essential.

Among the therapeutic options, selective serotonin reuptake inhibitors (SSRIs), with sertraline as the drug of first choice due to its low transplacental transfer and proven safety profile during breastfeeding, represent the most widely supported treatment regimen.

In psychiatric emergencies, such as active suicidal ideation with intent or the onset of postpartum psychosis—a rare but serious clinical condition characterized by delusions, hallucinations, and a risk of infanticide or self-harm—immediate hospitalization in specialized maternal-child mental health units is indicated.

In-hospital management requires safe medical containment, the supervised initiation of antipsychotics or mood stabilizers compatible with the clinical condition, continuous support, and the development of a safety plan that protects the physical well-being of both the young mother and the newborn at all times.